NBO Pharma is a biotechnology company that develops drug for the treatment of Idiopathic Intracranial Hypertension.
NBO Pharma has raised $7.6M in total funding. The most recent round was Seed. The last funding was announced in January 2026.
NBO Pharma is headquartered in Bedford, United States.
NBO Pharma is a biotechnology company that develops drug for the treatment of Idiopathic Intracranial Hypertension.
NBO Pharma is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NBO Pharma — Funding & Investors." VCBacked, January 22, 2026, https://www.vcbacked.co/company/nbo-pharma. Accessed August 1, 2026.
VCBacked. (2026). NBO Pharma — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/nbo-pharma
{{cite web |title=NBO Pharma — Funding & Investors |url=https://www.vcbacked.co/company/nbo-pharma |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated